|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.170 USD | -2.58% |
|
+0.42% | -51.94% |
| Capitalization | 1.91B 1.63B 1.52B 1.43B 2.64B 173B 2.88B 17.77B 6.89B 81.7B 7.18B 7.03B 298B | P/E ratio 2025 * |
3.81x | P/E ratio 2026 * | 2.64x |
|---|---|---|---|---|---|
| Enterprise value | 9.71B 8.27B 7.73B 7.27B 13.39B 880B 14.62B 90.21B 34.99B 415B 36.44B 35.67B 1,513B | EV / Sales 2025 * |
1.56x | EV / Sales 2026 * | 1.42x |
| Free-Float |
99.82% | Yield 2025 * |
4.62% | Yield 2026 * | 9.78% |
Last Transcript: Organon & Co.
| 1 day | -2.58% | ||
| 1 week | +0.42% | ||
| Current month | -7.00% | ||
| 1 month | -7.00% | ||
| 3 months | -32.68% | ||
| 6 months | -28.80% | ||
| Current year | -51.94% |
| 1 week | 6.9 |  | 7.49 |
| 1 month | 6.9 | | 7.88 |
| Current year | 6.18 | | 17.23 |
| 1 year | 6.18 | | 17.23 |
| 3 years | 6.18 | | 32.43 |
| 5 years | 6.18 | | 39.48 |
| 10 years | 6.18 | | 39.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Morrissey
CEO | Chief Executive Officer | 60 | 25/10/2025 |
Matthew Walsh
DFI | Director of Finance/CFO | 58 | 01/06/2021 |
| Chief Tech/Sci/R&D Officer | 55 | 04/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Carrie Cox
CHM | Chairman | 67 | 01/06/2021 |
Robert Essner
BRD | Director/Board Member | 77 | 01/06/2021 |
| Director/Board Member | 71 | 01/06/2021 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 15.92% | 303 M€ | -21.05% | - |
| 1.71% | 2 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.58% | +0.42% | -53.29% | -74.00% | 1.91B | |
| +1.80% | +1.70% | +31.34% | +179.78% | 904B | |
| +0.75% | +4.78% | +44.68% | +18.97% | 506B | |
| -0.29% | -1.22% | +28.95% | +35.08% | 396B | |
| -0.35% | +2.16% | +23.80% | +4.01% | 342B | |
| -1.12% | -0.52% | +27.58% | +18.41% | 283B | |
| -0.45% | -1.29% | +19.97% | +23.42% | 256B | |
| +1.30% | +0.58% | -0.94% | -7.96% | 246B | |
| +0.45% | +5.02% | -59.36% | -30.31% | 223B | |
| +0.11% | -3.68% | +15.94% | +14.80% | 171B | |
| Average | +0.03% | +0.25% | +7.87% | +18.22% | 332.89B | |
| Weighted average by Cap. | +0.65% | +0.26% | +21.80% | +57.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.23B 5.31B 4.96B 4.67B 8.59B 565B 9.39B 57.91B 22.46B 266B 23.39B 22.9B 971B | 6.18B 5.27B 4.92B 4.63B 8.52B 560B 9.31B 57.41B 22.27B 264B 23.19B 22.7B 963B |
| Net income | 502M 428M 399M 376M 692M 45.47B 756M 4.66B 1.81B 21.43B 1.88B 1.84B 78.2B | 733M 624M 583M 549M 1.01B 66.39B 1.1B 6.81B 2.64B 31.3B 2.75B 2.69B 114B |
| Net Debt | 7.8B 6.64B 6.21B 5.84B 10.75B 706B 11.74B 72.43B 28.1B 333B 29.26B 28.64B 1,215B | 6.86B 5.85B 5.46B 5.14B 9.46B 622B 10.34B 63.75B 24.73B 293B 25.75B 25.21B 1,069B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 7.170 $ | -2.58% | 4,676,896 |
| 11/12/25 | 7.360 $ | +2.51% | 4,386,864 |
| 10/12/25 | 7.180 $ | +3.31% | 7,204,243 |
| 09/12/25 | 6.950 $ | -4.66% | 5,317,859 |
| 08/12/25 | 7.290 $ | +2.10% | 5,009,423 |
Delayed Quote Nyse, December 12, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition